Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Conservative Site-specific Recombination and Phase Variation

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

DVD-IgG1 antibody-drug conjugates: Expanding the landscape of targeted cancer therapy.

Current opinion in chemical biology·2026

Same author

Discovery of 5‑Chlorotryptophan-Containing Antibiotics through Metabologenomics-Assisted High-Throughput Screening.

JACS Au·2025

Same author

Chemical Tagging of <i>N</i>-Alkylamine-Containing Natural Products and Pharmaceuticals through C(<i>sp</i><sup>3</sup>)-H Functionalization.

Journal of the American Chemical Society·2025

Same author

Logical Exploration of Cinnamoyl-Containing Nonribosomal Peptides via Metabologenomic Targeting and Regulator Overexpression.

Journal of the American Chemical Society·2025

Same author

Second Generation Tiancimycin-Based Antibody-Drug Conjugates Enabled by Highly Efficient Semi-synthetic Approach Specifically Targeting B-Cell Malignancies.

JACS Au·2025

Same author

Coenzyme A Tethering Mediates Dehydratase Substrate Promiscuity and Reaction Specificity in Platensimycin, Platencin, and Platensilin Biosynthesis.

Biochemistry·2025

Search research articles

Related Experiment Video

Updated: May 20, 2026

Electrochemotherapy of Tumours

Electrochemotherapy of Tumours

Published on: December 15, 2008

A designer bleomycin with significantly improved DNA cleavage activity.

Sheng-Xiong Huang¹, Zhiyang Feng, Liyan Wang

¹Department of Chemistry, The Scripps Research Institute, Jupiter, Florida 33458, USA.

Journal of the American Chemical Society

|July 27, 2012

Summary

Engineered bleomycin (BLM) analogues show promise for cancer treatment. The novel 6'-deoxy-BLM Z exhibits potent DNA cleavage activity, suggesting potential for reduced lung toxicity in chemotherapy.

More Related Videos

Single Molecule Analysis of Laser Localized Psoralen Adducts

Single Molecule Analysis of Laser Localized Psoralen Adducts

Published on: April 20, 2017

Dual Immunofluorescence of γH2AX and 53BP1 in Human Peripheral Lymphocytes

Dual Immunofluorescence of γH2AX and 53BP1 in Human Peripheral Lymphocytes

Published on: July 14, 2023

Related Experiment Videos

Last Updated: May 20, 2026

Electrochemotherapy of Tumours

Electrochemotherapy of Tumours

Published on: December 15, 2008

Single Molecule Analysis of Laser Localized Psoralen Adducts

Single Molecule Analysis of Laser Localized Psoralen Adducts

Published on: April 20, 2017

Dual Immunofluorescence of γH2AX and 53BP1 in Human Peripheral Lymphocytes

Dual Immunofluorescence of γH2AX and 53BP1 in Human Peripheral Lymphocytes

Published on: July 14, 2023

Area of Science:

Biochemistry
Molecular Biology
Pharmacology

Background:

Bleomycins (BLMs) are crucial in cancer chemotherapy, but lung toxicity limits their use.
Developing novel BLM analogues with improved efficacy and reduced side effects is a priority.

Purpose of the Study:

To engineer and evaluate novel bleomycin analogues for enhanced anticancer activity and potentially lower toxicity.
To investigate the role of the disaccharide moiety in the DNA cleavage activity of BLMs and zorbamycins (ZBMs).

Main Methods:

Cloned and characterized biosynthetic gene clusters for BLMs, tallysomycins, and zorbamycin (ZBM).
Engineered production of three new analogues: 6 ahydroxy-ZBM, BLM Z, and 6 deoxy-BLM Z.
Evaluated the DNA cleavage activities of the engineered analogues.

Main Results:

The disaccharide moiety is critical for the DNA cleavage activity of BLMs and ZBMs.
The ZBM disaccharide significantly boosts the potency of BLM.
6 deoxy-BLM Z demonstrated the highest potency among the tested BLM analogues.

Conclusions:

Engineered bleomycin analogues, particularly 6 deoxy-BLM Z, show significant potential as anticancer agents.
Microbial fermentation of 6 deoxy-BLM Z facilitates further preclinical development for clinical application.